Latest News

Amer Sports recently reported a strong first quarter of 2026, with revenue, adjusted margins, and earnings per share all exceeding expectations on the back of broad-based brand, channel, and regional strength. Growth was especially powered by Salomon’s apparel and Arc’teryx’s omnichannel performance, as both direct-to-consumer and wholesale channels delivered double-digit revenue gains across every major geography. We’ll now examine how Amer Sports’ broad-based outperformance, particularly...

How Ladder Capital Stock Has Been Performing Recently Ladder Capital (LADR) has drawn investor attention after a mixed run in its share price, with the stock down over the year to date but showing gains over the past 3 months and year. This performance sits against reported revenue of $216.26 million and net income of $55.012 million, figures that help frame how the market is currently pricing this US$1.31b real estate investment trust. See our latest analysis for Ladder Capital. The latest...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Coach, part of Tapestry (NYSE:TPR), has launched &Coach, a digital luxury content platform co-created with Gen Z. The platform focuses on social first storytelling and participatory campaigns, with younger creators embedded in the process. &Coach is intended to reshape how the Coach brand builds community and relevance with younger luxury consumers. Tapestry, trading at $145.87, sits behind Coach as its flagship brand and is leaning into a content driven approach to connect with younger...

Tariffs, shifting trade rules, and pressure on global supply chains are reshaping how investors think about US manufacturing stocks. Instead of relying on smooth cross-border trade, markets are reassessing companies that produce more at home and can better control their costs and inputs. This article looks at three US Domestic Manufacturing screener stocks that are directly exposed to these trade headlines and may react in different ways as policies evolve. Each stock is assessed on its...

With Kevin Warsh preparing for his first post-meeting press conference and the Federal Reserve keeping rates at 3.6% while inflation sits at 4.2%, many investors are rethinking how much risk they want to carry. Large-cap defensive stocks, often backed by steady dividends and stronger balance sheets, can look relatively appealing when rate cuts seem less likely and market swings pick up. This article highlights 3 stocks from our Large-Cap Defensive Stocks screener that appear positively...

With markets under pressure from a more hawkish Federal Reserve tone, rising 10-year Treasury yields, and broad weakness across sectors, it can feel harder than ever to decide which large-cap stocks deserve space in your portfolio. Quality, financial strength, and consistent execution take on extra importance when borrowing costs rise and megacap tech stocks such as Meta, Microsoft, and Amazon come under renewed scrutiny. This article highlights three large-cap stocks from a Quality Large-Cap...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Furukawa Electric (TSE:5801) issued fresh consolidated guidance for the fiscal year ending March 31, 2027, outlining targets of ¥1,460,000 million in net sales, ¥95,000 million in operating profit, and ¥82,000 million in profit attributable to shareholders. See our latest analysis for Furukawa Electric. Furukawa Electric's latest guidance arrives after a sharp move in the share price, with a 1-day share price return of 2.84% and a 7-day share price return of 15.59%, offset by a 30-day share...

Cosa Resources' summer drilling plans at the Darby joint venture have put Denison Mines (TSX:DML) back in focus, as investors weigh what renewed work on the Gamma and Bravo trends could mean for the uranium explorer. See our latest analysis for Denison Mines. At a share price of CA$4.69, Denison Mines has seen a 19.04% 7 day share price return and a 13.29% year to date share price return. Its 1 year total shareholder return of 87.60% and 3 year total shareholder return of 184.24% point to...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Engineers India Limited ( NSE:ENGINERSIN ), might not be a large cap stock, but it received a lot of attention from a...

With the Federal Reserve hinting at possible rate hikes in 2026 and inflation holding at 4.2%, value stocks are back in focus for investors who care about price tags as much as potential. Higher-for-longer rates can reward companies with resilient balance sheets and sensible valuations, while putting pressure on those priced for perfection. This article highlights three value stocks from our screener that are closely exposed to the latest Fed and inflation news. It explains why some investors...

Renault (ENXTPA:RNO) has taken full control of Flexis after receiving regulatory approval, a move directly linked to its plan to launch the Renault Trafic Van E Tech electric on a Software Defined Vehicle platform. See our latest analysis for Renault. Despite the push into Software Defined Vehicles and defense-related projects, Renault’s 1-year total shareholder return is down 24.21%, and the share price has fallen 25.11% year to date to €27.23, pointing to weak recent momentum. If this kind...

AAON (AAON) raised its 2026 revenue growth outlook to 40% to 45%, citing record backlog, expanding capacity, and improving production execution, particularly at BASX, as key supports for the stock's recent move. See our latest analysis for AAON. The latest guidance upgrade lands on top of strong momentum in AAON stock, with a 90 day share price return of 66.6% and a 1 year total shareholder return of 86.58%. However, the 30 day share price move has been roughly flat, which may hint that...

In recent months, UroGen Pharma resolved a patent dispute with Teva Pharmaceuticals by granting a non-exclusive license for a generic version of Jelmyto starting 15 September 2030, while reporting modest Jelmyto growth and significantly stronger first-quarter sales for its newer therapy, Zusduri. This combination of a long-dated generic entry and early commercial momentum for Zusduri reshapes how investors weigh UroGen’s product concentration and revenue-risk profile. With the Teva...

Insider Selling and Valuation Concerns Put Impinj Stock in Focus Impinj (PI) shares fell 5.0% on June 16, 2026, after renewed attention on valuation, with the stock trading 5.5% above its estimated intrinsic value and recent insider selling totaling US$49.4 million. See our latest analysis for Impinj. The latest drop in Impinj's share price fits into a mixed picture, with a 23.29% 90 day share price return contrasting with a year to date share price decline of 31.35%. At the same time, the 5...

In mid-June 2026, Toronto-Dominion Bank completed several fixed-income offerings across US$, £ and C$ markets and reported strong Q2 performance with record earnings in multiple divisions, alongside a 3.7% increase in its quarterly dividend. Together with higher analyst confidence and continued growth in its ETF and mutual fund platforms, these moves highlight TD’s focus on diversified funding and reinforcing its role across both traditional and digital wealth channels. With TD’s record...

Potential Yamada Green Resources Limited ( SGX:BJV ) shareholders may wish to note that the Founder, Qiuhai Chen...

Insiders who bought Goldway Education Group Limited ( HKG:8160 ) stock lover the last 12 months are probably not as...

Andrew Peller (TSX:ADW.A) has just reported its FY 2026 results with Q4 revenue of $79.5 million and net income of $5.7 million, while the shares trade around $7.93. The company has seen quarterly revenue range from $75.5 million in Q4 FY 2025 to $108.8 million in Q3 FY 2026, with EPS moving from a small loss of $0.02 in Q4 FY 2025 to $0.20 in Q2 FY 2026. This gives investors a clearer picture of how the top and bottom lines have shifted over the year. With trailing net margin running at 6.9%...

If you are wondering whether Corcept Therapeutics stock is still attractively priced after a strong run, the key question now is how its current share price compares with a reasonable view of fair value. The stock last closed at US$81.75, with returns of 4.6% over the past week, 48.3% over the past month, 114.0% year to date, 14.8% over the past year, 264.0% over three years, and 267.3% over five years. These figures naturally raise questions about how much of the story might already be...

The Fed’s hawkish turn, with rates held at 3.5 to 3.75% and the next move likely a hike, has quickly reshaped expectations for dividend stocks. Higher yields on cash and bonds can pressure income stocks, but solid dividend growth companies with healthy balance sheets can still play a role for investors looking for reliable cash flows and potential income growth. This article looks at three dividend growth stocks from our screener that appear well positioned against this new rate backdrop and...

Adyen (ENXTAM:ADYEN) stock is back in focus after the company introduced Adyen Agentic, a suite of APIs that connects enterprise merchants to conversational AI commerce channels through a single integration. See our latest analysis for Adyen. The Adyen share price has been volatile, with a 7 day share price return of 10.61%, a year to date share price return down 36.42%, and a 1 year total shareholder return down 44.61%. Recent AI and billing announcements appear to be lifting sentiment off a...